JP2005517731A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005517731A5 JP2005517731A5 JP2003569585A JP2003569585A JP2005517731A5 JP 2005517731 A5 JP2005517731 A5 JP 2005517731A5 JP 2003569585 A JP2003569585 A JP 2003569585A JP 2003569585 A JP2003569585 A JP 2003569585A JP 2005517731 A5 JP2005517731 A5 JP 2005517731A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- optionally
- halogen
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 27
- 125000003118 aryl group Chemical group 0.000 claims 15
- 229910052736 halogen Inorganic materials 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 125000004104 aryloxy group Chemical group 0.000 claims 5
- 150000007942 carboxylates Chemical class 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- -1 hydroxy, hydroxy Chemical group 0.000 claims 3
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 claims 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 claims 1
- VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical compound C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 claims 1
- JVQIKJMSUIMUDI-UHFFFAOYSA-N 3-pyrroline Chemical compound C1NCC=C1 JVQIKJMSUIMUDI-UHFFFAOYSA-N 0.000 claims 1
- VJPPDEZWWKCSIV-UHFFFAOYSA-N 6-azabicyclo[3.2.1]octane Chemical compound C1C2CNC1CCC2 VJPPDEZWWKCSIV-UHFFFAOYSA-N 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 claims 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 102000015694 estrogen receptors Human genes 0.000 claims 1
- 108010038795 estrogen receptors Proteins 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000003003 spiro group Chemical group 0.000 claims 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075727 | 2002-02-22 | ||
| EP02075729 | 2002-02-22 | ||
| PCT/EP2003/050018 WO2003070675A2 (en) | 2002-02-22 | 2003-02-14 | Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005517731A JP2005517731A (ja) | 2005-06-16 |
| JP2005517731A5 true JP2005517731A5 (cg-RX-API-DMAC7.html) | 2006-03-23 |
| JP4647214B2 JP4647214B2 (ja) | 2011-03-09 |
Family
ID=27758768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003569585A Expired - Fee Related JP4647214B2 (ja) | 2002-02-22 | 2003-02-14 | エストロゲン受容体に対して選択的に作用させるための、置換10−アリール−11H−ベンゾ[b]フルオレン及び7−アリール−5,6−ジヒドロ−ベンゾ[a]アントラセン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7335659B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1478613B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4647214B2 (cg-RX-API-DMAC7.html) |
| AR (1) | AR038528A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE327214T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003208717A1 (cg-RX-API-DMAC7.html) |
| DE (2) | DE60305450T8 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2265098T3 (cg-RX-API-DMAC7.html) |
| PE (1) | PE20030981A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200304371A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003070675A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002016316A1 (en) * | 2000-08-23 | 2002-02-28 | Akzo Nobel N.V. | 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE |
| US6849348B2 (en) * | 2002-12-31 | 2005-02-01 | Eastman Kodak Company | Complex fluorene-containing compounds |
| US7157492B2 (en) * | 2004-02-26 | 2007-01-02 | Wyeth | Dibenzo chromene derivatives and their use as ERβ selective ligands |
| EP1806148A4 (en) * | 2004-10-22 | 2009-12-02 | Ono Pharmaceutical Co | THERAPEUTIC PREPARATION FOR INHALATION |
| KR20100109293A (ko) * | 2009-03-31 | 2010-10-08 | 다우어드밴스드디스플레이머티리얼 유한회사 | 신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계발광 소자 |
| WO2012068299A2 (en) * | 2010-11-16 | 2012-05-24 | University Of Southern California | Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells |
| CA2819299A1 (en) * | 2010-12-24 | 2012-06-28 | Merck Sharp & Dohme B.V. | N-substituted azetidine derivatives |
| CN107188901A (zh) * | 2017-05-27 | 2017-09-22 | 无锡捷化医药科技有限公司 | 一种(3‑(3‑(二甲氨基)丙氧基)苯基)硼酸的制备方法 |
| CN115785148B (zh) * | 2022-11-17 | 2024-12-10 | 江西科技师范大学 | 一种硫代膦(磷)酸酯取代苯并芴化合物的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223506A (en) | 1991-06-04 | 1993-06-29 | Glaxo Inc. | Cyclic antitumor compounds |
| US5147880A (en) | 1991-07-22 | 1992-09-15 | Eli Lilly And Company | Benzo[a]fluorene compounds |
| US5688808A (en) | 1994-12-22 | 1997-11-18 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
| AU717251B2 (en) | 1994-12-22 | 2000-03-23 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
| US6451817B1 (en) | 1995-03-10 | 2002-09-17 | Eli Lilly And Company | Alpha-substituted-1-benzyl-napthyls |
| JP3141148B2 (ja) | 1995-08-08 | 2001-03-05 | 大鵬薬品工業株式会社 | 縮合インダン誘導体及びその塩 |
| CA2200423C (en) | 1996-03-26 | 2006-12-19 | Sietse Mosselman | Novel estrogen receptor |
| CA2214935A1 (en) | 1996-09-26 | 1998-03-26 | Henry Uhlman Bryant | Benzofluorene compounds, intermediates, compositions, and methods |
| AU7467398A (en) | 1997-04-25 | 1998-11-24 | Eli Lilly And Company | Indene compounds having activity as serms |
| ES2293986T3 (es) * | 2000-03-27 | 2008-04-01 | N.V. Organon | Compuestos no esteroides tetraciclicos para tratamientos relacionados con el estrogeno. |
| WO2002016316A1 (en) * | 2000-08-23 | 2002-02-28 | Akzo Nobel N.V. | 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE |
-
2003
- 2003-02-07 TW TW092102579A patent/TW200304371A/zh unknown
- 2003-02-14 EP EP03706624A patent/EP1478613B1/en not_active Expired - Lifetime
- 2003-02-14 ES ES03706624T patent/ES2265098T3/es not_active Expired - Lifetime
- 2003-02-14 US US10/505,631 patent/US7335659B2/en not_active Expired - Lifetime
- 2003-02-14 AU AU2003208717A patent/AU2003208717A1/en not_active Abandoned
- 2003-02-14 DE DE60305450T patent/DE60305450T8/de active Active
- 2003-02-14 AT AT03706624T patent/ATE327214T1/de not_active IP Right Cessation
- 2003-02-14 DE DE60305450A patent/DE60305450D1/de not_active Expired - Lifetime
- 2003-02-14 JP JP2003569585A patent/JP4647214B2/ja not_active Expired - Fee Related
- 2003-02-14 WO PCT/EP2003/050018 patent/WO2003070675A2/en not_active Ceased
- 2003-02-18 PE PE2003000170A patent/PE20030981A1/es not_active Application Discontinuation
- 2003-02-20 AR ARP030100543A patent/AR038528A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2435757C2 (ru) | Производные 3-циклил-2-(4-сульфамоилфенил)-n-циклилпропионамида, применимые для лечения нарушенной переносимости глюкозы и диабета | |
| RU2412192C2 (ru) | Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2 | |
| RU2475487C2 (ru) | Имидазохинолины с иммуномодулирующими свойствами | |
| EP1428822A3 (en) | 1-phenylpiperazine derivative as modulators of dopamine neurotransmission | |
| JP2018520105A5 (cg-RX-API-DMAC7.html) | ||
| RU2330019C2 (ru) | Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и способ лечения хемокин-опосредованного болезненного состояния с их использованием | |
| JP2006521359A5 (cg-RX-API-DMAC7.html) | ||
| JP2008535803A5 (cg-RX-API-DMAC7.html) | ||
| ITMI20000312A0 (it) | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva | |
| CA2413086A1 (en) | Benzothiazole derivatives | |
| HUT69686A (en) | Process for preparing pharmaceutical compositions having serum cholesterol lowering effect | |
| AR047557A1 (es) | Compuestos derivados de piridazina y su uso como agentes terapeuticos | |
| JP2008536825A5 (cg-RX-API-DMAC7.html) | ||
| MY133992A (en) | Muscarinic antagonists | |
| AR031930A1 (es) | Antagonistas de mch y su uso en el tratamiento de la obesidad | |
| RU2015154955A (ru) | Производные бензотиофенов в качестве ингибиторов рецептора эстрогенов | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| GEP20115213B (en) | Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists | |
| JP2006523234A5 (cg-RX-API-DMAC7.html) | ||
| CO5140114A1 (es) | Derivados de aminoisoquinolina | |
| RU2006112847A (ru) | Производные тиазолопиридина в качестве лигандов аденозинового рецептора | |
| RU2007102224A (ru) | Производные индола в качестве антагонистов гистаминовых рецепторов | |
| RU2011117927A (ru) | Карбаматное соединение или его соль | |
| JP2005508969A5 (cg-RX-API-DMAC7.html) | ||
| RU2000124402A (ru) | Производные азетидина и пирролидина |